Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time
JS Berg, MJ Khoury, JP Evans - Genetics in medicine, 2011 - nature.com
Technological advances often outpace our ability to effec-tively use them, a situation that
certainly could pertain to modern genomics. Breathtaking advances in genetic sequencing …
certainly could pertain to modern genomics. Breathtaking advances in genetic sequencing …
ACMG SF v3. 0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and …
Clinicians are encouraged to document the reasons for the use of a particular procedure or
test, whether or not it is in conformance with this statement. Clinicians also are advised to …
test, whether or not it is in conformance with this statement. Clinicians also are advised to …
ACMG SF v3. 2 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and …
Disclaimer: This statement is designed primarily as an educational resource for medical
geneticists and other clinicians to help them provide quality medical services. Adherence to …
geneticists and other clinicians to help them provide quality medical services. Adherence to …
[HTML][HTML] Standards and guidelines for validating next-generation sequencing bioinformatics pipelines: a joint recommendation of the Association for Molecular …
Bioinformatics pipelines are an integral component of next-generation sequencing (NGS).
Processing raw sequence data to detect genomic alterations has significant impact on …
Processing raw sequence data to detect genomic alterations has significant impact on …
The Medical Genome Initiative: moving whole-genome sequencing for rare disease diagnosis to the clinic
Clinical whole-genome sequencing (WGS) offers clear diagnostic benefits for patients with
rare disease. However, there are barriers to its widespread adoption, including a lack of …
rare disease. However, there are barriers to its widespread adoption, including a lack of …
Not-so-incidental findings: the ACMG recommendations on the reporting of incidental findings in clinical whole genome and whole exome sequencing
Introduction The issue of incidental findings in genomics research has been contentious,
particularly in whole genome sequencing (WGS) and whole exome sequencing (WES). An …
particularly in whole genome sequencing (WGS) and whole exome sequencing (WES). An …
Advances in clinical next-generation sequencing: target enrichment and sequencing technologies
LY Ballester, R Luthra… - Expert Review of …, 2016 - Taylor & Francis
The huge parallel sequencing capabilities of next generation sequencing technologies have
made them the tools of choice to characterize genomic aberrations for research and …
made them the tools of choice to characterize genomic aberrations for research and …
Clinical sequencing: from raw data to diagnosis with lifetime value
SM Caspar, N Dubacher, AM Kopps… - Clinical …, 2018 - Wiley Online Library
High‐throughput sequencing (HTS) has revolutionized genetics by enabling the detection of
sequence variants at hitherto unprecedented large scale. Despite these advances, however …
sequence variants at hitherto unprecedented large scale. Despite these advances, however …
[HTML][HTML] A rigorous interlaboratory examination of the need to confirm next-generation sequencing–detected variants with an orthogonal method in clinical genetic …
Orthogonal confirmation of next-generation sequencing (NGS)-detected germline variants is
standard practice, although published studies have suggested that confirmation of the …
standard practice, although published studies have suggested that confirmation of the …
Harmonizing clinical sequencing and interpretation for the eMERGE III network
The advancement of precision medicine requires new methods to coordinate and deliver
genetic data from heterogeneous sources to physicians and patients. The eMERGE III …
genetic data from heterogeneous sources to physicians and patients. The eMERGE III …